keyboard_arrow_up

Chemiluminescence Immunoassay Market worth $19.1 Billion by 2018

The "Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer, Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)] - Global Forecast to 2018provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global immunoassays market along with the estimates and forecasts of the revenue and share analysis.

Download Free PDF @ Immunoassay Market

The immunoassay instruments and reagents had witnessed a tremendous change and significant innovation since their evolution in the early nineties. The global market is valued at about $13.0 billion in 2013 and is expected to grow at a healthy CAGR of 8.1% to reach $19.1 billion by 2018.

The global immunoassays market is consolidated, with the top seven market playe-Roche Diagnostics, Siemens Healthcare Diagnostics, Abbott Diagnostics, Danaher Corporation, Ortho Clinical Diagnostics, bioMérieux, and DiaSorin S.P.A-accounting for market shares of more than 85%. Roche is the market leader holding around one-fifth of the overall market share. The company offers a broad product portfolio with more than 100 assays in various disease categories, owing to which it enjoys a high level of customer loyalty. The company’s cobas analyzer series of products dominates the global immunoassays market. Roche also has easy access to all the regions worldwide as it has a well-established supply chain.

Among the Asia-Pacific countries, China and India are expected to grow at the highest CAGRs during the forecast period. Moreover, the opportunities for growth of the immunoassays industry in ROAP (Singapore, Indonesia, Malaysia, Thailand, Australia, New Zealand, and other Asia-Pacific countries) are also high because of the increasing focus of key players on these countries.

The chemiluminescence immunoassays market is estimated to witness tremendous growth in the next five years as this market comprises of automated systems that offer the highest sensitivity. In addition, the infectious diseases, endocrinology, and oncology application segments of the immunoassays market are projected to see high-growth rates owing to the increasing incidences of these disorders.

Thus, the CLIA technology along with infectious diseases and oncology applications provide huge opportunities for established as well as new investors. Moreover, the APAC region opens new avenues for them to invest in as developed markets saturate gradually.

Browse 118 market data tables with 86 figures spread through 421 pages and in-depth TOC on "Immunoassay Market"
http://www.marketsandmarkets.com/Market-Reports/immunoassay-market-436.html

Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Ortho Clinical Diagnostics (U.S.), Alere, Inc. (U.S.), Sysmex Corporation (Japan), and DiaSorin S.P.A. (Italy) are the key industry participants. The immunoassay market is dominated by established players and is consolidated, with the top 5 players occupying more than 80% of the market. The market offers huge barriers for new entrants as the industry demands high capital investments for R&D and testing and manufacturing of products. Moreover, companies have to follow stringent regulations to get product approvals in various countries.

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn@ http://www.linkedin.com/company/marketsandmarkets